Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00104182
Status:
COMPLETED
Last Update Posted:
2017-01-30
First Post:
2005-02-23
Brief Title:
Comparison of Insulin Detemir Morning Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
Efficacy and Safety Comparison of Insulin Detemir Morning Insulin Detemir Evening and NPH Insulin Evening as Add-on to Oral Antidiabetic Drugs in Patients With Type 2 Diabetes
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in Europe and the United States of America USA The aim of this trial is to compare the use of Insulin Detemir once a day morning or evening to NPH Insulin once a day evening when added to treatment with oral antidiabetic drugs in patients with Type 2 diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-001461-18 | EUDRACT_NUMBER | None | None |